This study sought to assess whether low-dose aspirin benefits individuals with elevated plasma lipoprotein(a)-associated genotypes in the setting of primary prevention.
Editors
Editor-in-Chief Valentin Fuster, MD, PhD, MACC
CME EditorRagavendra R. Baliga, MD
Authors Harpreet S. Bhatia, MDPaul Lacaze, PhD Sotirios Tsimikas, MD
Date of Release: September 26, 2022 Term of Approval/Date of CME/MOC/ECME Expiration: September 25, 2023